113 related articles for article (PubMed ID: 10637490)
1. Establishment and characterization of a new human megakaryoblastic cell line (SET-2) that spontaneously matures to megakaryocytes and produces platelet-like particles.
Uozumi K; Otsuka M; Ohno N; Moriyama T; Suzuki S; Shimotakahara S; Matsumura I; Hanada S; Arima T
Leukemia; 2000 Jan; 14(1):142-52. PubMed ID: 10637490
[TBL] [Abstract][Full Text] [Related]
2. A newly established megakaryoblastic/erythroid cell line that differentiates to red cells in the presence of erythropoietin and produces platelet-like particles.
Tsuyuoka R; Takahashi T; Suzuki A; Sasaki Y; Nakamura K; Fukumoto M; Ohmori K; Ohno Y; Nakao K
Stem Cells; 1995 Jan; 13(1):54-64. PubMed ID: 7719248
[TBL] [Abstract][Full Text] [Related]
3. Effects of c-mpl ligand on cytoplasmic maturation of murine megakaryocytes and on platelet production.
Ishida Y; Ito T; Kuriya Si
J Histochem Cytochem; 1998 Jan; 46(1):49-57. PubMed ID: 9405494
[TBL] [Abstract][Full Text] [Related]
4. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
[TBL] [Abstract][Full Text] [Related]
5. Production of functional platelet-like particles by the megakaryoblastic DAMI cell line provides a model for platelet biogenesis.
Lev PR; Goette NP; Glembotsky AC; Laguens RP; Meckert PM; Salim JP; Heller PG; Pozner RG; Marta RF; Molinas FC
Platelets; 2011; 22(1):28-38. PubMed ID: 21143024
[TBL] [Abstract][Full Text] [Related]
6. Cloning and functional characterization of a novel c-mpl variant expressed in human CD34 cells and platelets.
Li J; Sabath DF; Kuter DJ
Cytokine; 2000 Jul; 12(7):835-44. PubMed ID: 10880227
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of erythroid differentiation and induction of megakaryocytic differentiation by thrombopoietin are regulated by two different mechanisms in TPO-dependent UT-7/c-mpl and TF-1/c-mpl cell lines.
Goncalves F; Lacout C; Féger F; Cohen-Solal K; Guichard J; Cramer E; Vainchenker W; Duménil D
Leukemia; 1998 Sep; 12(9):1355-66. PubMed ID: 9737683
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival.
Komatsu N; Nakauchi H; Miwa A; Ishihara T; Eguchi M; Moroi M; Okada M; Sato Y; Wada H; Yawata Y
Cancer Res; 1991 Jan; 51(1):341-8. PubMed ID: 1824823
[TBL] [Abstract][Full Text] [Related]
9. Binding and regulation of thrombopoietin to human megakaryocytes.
Sato T; Fuse A; Niimi H; Fielder PJ; Avraham H
Br J Haematol; 1998 Mar; 100(4):704-11. PubMed ID: 9531337
[TBL] [Abstract][Full Text] [Related]
10. Thrombocytopenia in c-mpl-deficient mice.
Gurney AL; Carver-Moore K; de Sauvage FJ; Moore MW
Science; 1994 Sep; 265(5177):1445-7. PubMed ID: 8073287
[TBL] [Abstract][Full Text] [Related]
11. Morphologic and flow cytometric analysis of circulating megakaryoblasts in chronic myeloid leukaemia.
Matolcsy A; Kálmán E; Pajor L; Kónya T; Weber E
Leuk Res; 1991; 15(10):887-97. PubMed ID: 1921449
[TBL] [Abstract][Full Text] [Related]
12. The platelet thrombopoietin receptor number and function are markedly decreased in patients with essential thrombocythaemia.
Li J; Xia Y; Kuter DJ
Br J Haematol; 2000 Dec; 111(3):943-53. PubMed ID: 11122159
[TBL] [Abstract][Full Text] [Related]
13. Human platelets and megakaryocytes express defensin alpha 1.
Valle-Jiménez X; Ramírez-Cosmes A; Aquino-Domínguez AS; Sánchez-Peña F; Bustos-Arriaga J; Romero-Tlalolini MLÁ; Torres-Aguilar H; Serafín-López J; Aguilar Ruíz SR
Platelets; 2020; 31(3):344-354. PubMed ID: 31116063
[TBL] [Abstract][Full Text] [Related]
14. Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production.
Horie K; Miyazaki H; Hagiwara T; Tahara E; Matsumoto A; Kadoya T; Ogami K; Kato T
Exp Hematol; 1997 Feb; 25(2):169-76. PubMed ID: 9015217
[TBL] [Abstract][Full Text] [Related]
15. Platelet-like particle production from cultured human megakaryocytic cell line.
Ikebuchi K; Yamaguchi M; Niwa K; Abe H; Fujihara M; Sekiguchi S
Artif Cells Blood Substit Immobil Biotechnol; 1998 Nov; 26(5-6):549-58. PubMed ID: 9844720
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 and interleukin-11 act synergistically with thrombopoietin and stem cell factor to modulate ex vivo expansion of human CD41+ and CD61+ megakaryocytic cells.
Lazzari L; Henschler R; Lecchi L; Rebulla P; Mertelsmann R; Sirchia G
Haematologica; 2000 Jan; 85(1):25-30. PubMed ID: 10629587
[TBL] [Abstract][Full Text] [Related]
17. Developmental Stage-Specific Manifestations of Absent TPO/c-MPL Signalling in Newborn Mice.
Lorenz V; Ramsey H; Liu ZJ; Italiano J; Hoffmeister K; Bihorel S; Mager D; Hu Z; Slayton WB; Kile BT; Sola-Visner M; Ferrer-Marin F
Thromb Haemost; 2017 Dec; 117(12):2322-2333. PubMed ID: 29212120
[TBL] [Abstract][Full Text] [Related]
18. Compared effects of Mpl ligand and other cytokines on human MK differentiation.
Vitrat N; Cohen-Solal K; Norol F; Guichard J; Cramer E; Vainchenker W; Wendling F; Debili N
Stem Cells; 1998; 16 Suppl 2():37-51. PubMed ID: 11012176
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human megakaryocyte growth and development factor (rHuMGDF), a ligand for c-Mpl, produces functional human platelets in vitro.
Choi ES; Hokom M; Bartley T; Li YS; Ohashi H; Kato T; Nichol JL; Skrine J; Knudten A; Chen J
Stem Cells; 1995 May; 13(3):317-22. PubMed ID: 7542117
[TBL] [Abstract][Full Text] [Related]
20. Milestones in understanding platelet production: a historical overview.
Kuter DJ
Br J Haematol; 2014 Apr; 165(2):248-58. PubMed ID: 24528208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
